Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Pain × Glucose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1 Cancer Pain 1

Interventions

Lidocaine 3 aluminum hydroxide, magnesium hydroxide, drug combination 1 Water 1 Transdermal Patch 1 Radiosurgery 1 Methadone 1 Melatonin 1 Glucose 1 Fentanyl 1 Diphenhydramine 1 Diazepam 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡